Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kowey

Showing results (171-180 of 451) with videos related to

Pageof 46
Sort By:
Archives of Internal Medicine|November 27, 1995
Gender differences in device therapy for malignant ventricular arrhythmiasH L Horton, R A Marinchak, S J Rials, et al.
American Heart Journal|June 30, 2000
Classification and pharmacology of antiarrhythmic drugsP R Kowey, R A Marinchak, S J Rials, et al.
The Canadian Journal of Cardiology|May 1, 1991
Propafenone in the treatment of patients with malignant ventricular tachyarrhythmiasP R Kowey, J L Stohler, T D Friehling, et al.
Journal of Cardiovascular Pharmacology|September 1, 1989
Acute electrophysiologic effects and antiarrhythmic/antifibrillatory activity of intravenous amiodarone in a chronic feline infarction modelR A Marinchak, K M O'Connor, T D Friehling, et al.
Heart, Lung & Circulation|November 6, 2018
Pharmacological Therapy for Ventricular Arrhythmias: A State-of-the Art ReviewKarin K M Chia, Logan Kanagaratnam, Kevin Hellestrand, et al.
Circulation|September 30, 1998
A broken heartH Z Brandspiegel, R A Marinchak, S J Rials, et al.
The American Journal of Cardiology|April 3, 1998
Acute treatment of atrial fibrillationP R Kowey, R A Marinchak, S J Rials, et al.
Journal of the American College of Cardiology|May 1, 1997
Intravenous amiodaroneP R Kowey, R A Marinchak, S J Rials, et al.
Journal of Cardiovascular Electrophysiology|October 1, 1995
Parenteral antiarrhythmics for life-threatening ventricular arrhythmiasR A Filart, S J Rials, R A Marinchak, et al.
Drugs in R&D|March 18, 2011
Cardiovascular safety profile of dapoxetine during the premarketing evaluationPeter R Kowey, Ramagopal V Mudumbi, Joseph W Aquilina, et al.
Pageof 46

Showing results (171-180 of 451) with videos related to

Sort By:
Pageof 46
Archives of Internal Medicine|November 27, 1995
Gender differences in device therapy for malignant ventricular arrhythmiasH L Horton, R A Marinchak, S J Rials, et al.
American Heart Journal|June 30, 2000
Classification and pharmacology of antiarrhythmic drugsP R Kowey, R A Marinchak, S J Rials, et al.
The Canadian Journal of Cardiology|May 1, 1991
Propafenone in the treatment of patients with malignant ventricular tachyarrhythmiasP R Kowey, J L Stohler, T D Friehling, et al.
Journal of Cardiovascular Pharmacology|September 1, 1989
Acute electrophysiologic effects and antiarrhythmic/antifibrillatory activity of intravenous amiodarone in a chronic feline infarction modelR A Marinchak, K M O'Connor, T D Friehling, et al.
Heart, Lung & Circulation|November 6, 2018
Pharmacological Therapy for Ventricular Arrhythmias: A State-of-the Art ReviewKarin K M Chia, Logan Kanagaratnam, Kevin Hellestrand, et al.
Circulation|September 30, 1998
A broken heartH Z Brandspiegel, R A Marinchak, S J Rials, et al.
The American Journal of Cardiology|April 3, 1998
Acute treatment of atrial fibrillationP R Kowey, R A Marinchak, S J Rials, et al.
Journal of the American College of Cardiology|May 1, 1997
Intravenous amiodaroneP R Kowey, R A Marinchak, S J Rials, et al.
Journal of Cardiovascular Electrophysiology|October 1, 1995
Parenteral antiarrhythmics for life-threatening ventricular arrhythmiasR A Filart, S J Rials, R A Marinchak, et al.
Drugs in R&D|March 18, 2011
Cardiovascular safety profile of dapoxetine during the premarketing evaluationPeter R Kowey, Ramagopal V Mudumbi, Joseph W Aquilina, et al.
Pageof 46